Quick Answer
PURE BIOSCIENCE, INC. reported Diluted EPS of $0.02 per share (loss) for fiscal year 2025.
PURE BIOSCIENCE, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.02 | +33.3% |
| 2024 | -$0.03 | +25.0% |
| 2023 | -$0.04 | +0.0% |
| 2022 | -$0.04 | -33.3% |
| 2021 | -$0.03 | — |
| 2020 | $0.00 | +100.0% |
| 2019 | -$0.09 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$0.01 | +0.0% | — |
| October 31, 2025 | $0.00 | +100.0% | +100.0% |
| April 30, 2025 | -$0.01 | +0.0% | +0.0% |
| January 31, 2025 | -$0.01 | +0.0% | +0.0% |
| October 31, 2024 | -$0.01 | +0.0% | +0.0% |
| April 30, 2024 | -$0.01 | +0.0% | +0.0% |
| January 31, 2024 | -$0.01 | +50.0% | +0.0% |
| October 31, 2023 | -$0.01 | +0.0% | +0.0% |
- PURE BIOSCIENCE, INC. showed an increase of +33.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, PURE BIOSCIENCE, INC.’s diluted eps has grown by 77.8% (from $0.09 per share (loss) to $0.02 per share (loss)).
- The most recent figure is from PURE BIOSCIENCE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: